ARTICLE | Company News

Orexo, Paladin, ProStrakan, Kyowa Hakko Kirin sales and marketing update

April 11, 2011 7:00 AM UTC

ProStrakan launched Abstral fentanyl in the U.S. to treat breakthrough cancer pain. The sublingual mucoadhesive fentanyl is only available through a REMS program under which pharmacies, distributors and health care professionals must enroll in the program to prescribe, dispense and distribute the drug. Further terms were not disclosed. ...